LB
Healthcare & Life Sciences
Luxna Biotech
Luxna Biotech is a Healthcare & Life Sciences startup based in Japan, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Luxna Biotech
Based in Japan, Luxna Biotech is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Luxna Biotech develops safe and effective oligonucleotide therapeutics based on licensed cross-linked modified nucleic acids that strongly bind target mRNA, enhancing efficacy while reducing hepatotoxicity risks.
Explore Luxna Biotech's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.